I take an oral bisphosphonate. Am I at risk for osteonecrosis of the jaw?
If you use a bisphosphonate medication-to prevent or treat osteoporosis (a thinning of the bones) or as part of cancer treatment therapy-you should advise your dentist. In fact, any time your health history or medications change, you should make sure the dental office has the most recent information in your patient file. Here’s why: Some bisphosphonate medications (such as Fosamax, Actonel, Boniva) are taken orally (swallowed) to help prevent or treat osteoporosis and Paget’s disease of the bone. Others, such as Aredia, Bonefos, Didronel or Zometa, are administered intravenously (injected into a vein) as part of cancer therapy to reduce bone pain and hypercalcemia of malignancy (abnormally high calcium levels in the blood), associated with metastatic breast cancer, prostate cancer and multiple myeloma. In rare instances, some individuals receiving intravenous bisphosphonates for cancer treatment have developed osteonecrosis (pronounced OSS-tee-oh-ne-KRO-sis) of the jaw, a rare bu
Related Questions
- Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?
- Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?
- What is osteonecrosis or the jaw and what is its link to bisphosphonate use?
- What is osteonecrosis or the jaw and what is its link to bisphosphonate use?
- Should We Be Concerned About Jaw Osteonecrosis with Oral Bisphosphonates?
- I take an oral bisphosphonate. Am I at risk for osteonecrosis of the jaw?
